2023 Form 5500 filing — Dendreon 401(K) Plan
Plain-English filing summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20240730122652NAL0013378675001) for Dendreon 401(K) Plan, reported by Dendreon Pharmaceuticals LLC under EIN 22-3203193 and plan number 002. It reports 661 participants. Attached schedules in the loaded dataset include Schedule H (large plan financials), Schedule C (service provider compensation).
- EFAST2 acknowledgement
- 20240730122652NAL0013378675001
- Filing year
- 2023
- Form type
- 2
- Plan sponsor
- Dendreon Pharmaceuticals LLC
- EIN
- 22-3203193
- Plan number
- 002
- Location
- Seal Beach, CA
- Participants
- 661
- Schedules available
- Schedule H, Schedule C
- Received date
- not reported in the loaded dataset
Reported financial snapshot (2023)
- Total assets (EOY)
- $46,334,472
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $46,334,472
- Employer contributions
- $2,316,710
- Participant contributions
- $5,063,144
- Total income / additions
- $15,734,346
- Benefits paid
- $5,144,223
- Administrative expenses
- $73,825
- Total expenses
- $5,218,048
- Net increase / (decrease)
- $10,516,298
- Schedule source
- Schedule H
Reported service provider compensation (Schedule C)
| Provider | Service | Direct comp. | Indirect comp. |
|---|---|---|---|
| Fidelity Investments Institutional | RECORDKEEPER | $73,825 | $0 |